Clinical and metabolic effects of gestodene and levonorgestrel.

International journal of fertility

Volumn 32 Suppl, Issue , 1987, Pages 29-44

  Rabe, T ^a   Runnebaum, B ^a   Kohlmeier, M ^a   Harenberg, J ^a   Weicker, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GESTODENE; LEVONORGESTREL; LIPID; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PREGNANE DERIVATIVE; PROGESTERONE DERIVATIVE;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BIOLOGY; BLEEDING; BLOOD; BLOOD PRESSURE--CHANGES; BODY WEIGHT--CHANGES; CARBOHYDRATE METABOLIC EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRACEPTION; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE METHODS; DATA ANALYSIS; DEVELOPED COUNTRY; DISEASES; DRUG EFFECT; EUROPE; FAMILY PLANNING; FEMALE; GERMANY, FEDERAL REPUBLIC OF; GESTODENE--ADMINISTRACTION AND DOSAGE; GLUCOSE BLOOD LEVEL; HEMIC SYSTEM; HUMAN; INCIDENCE; LEVONORGESTREL--ADMINISTRACTION AND DOSAGE; LEVONORGESTREL--SIDE EFFECTS; LIPID METABOLIC EFFECTS; LONGITUDINAL STUDY; MEASUREMENT; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDER; METABOLIC EFFECTS; METHODOLOGY; METRORRHAGIA; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; ORAL CONTRACEPTIVES, LOW-DOSE; PHYSICAL DISEASE BY BODY FUNCTION; PHYSIOLOGY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; STEREOISOMERISM; STEROID METABOLIC EFFECTS--ANALYSIS; STUDIES; WESTERN EUROPE;

AMENORRHEA; BIOLOGY; BLEEDING; BLOOD PRESSURE--CHANGES; BODY WEIGHT--CHANGES; CARBOHYDRATE METABOLIC EFFECTS; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE AGENTS, ESTROGEN; CONTRACEPTIVE AGENTS, FEMALE--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--ADMINISTRACTION AND DOSAGE; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE METHODS; DATA ANALYSIS; DEVELOPED COUNTRIES; DISEASES; ETHINYL ESTRADIOL; EUROPE; FAMILY PLANNING; GERMANY, FEDERAL REPUBLIC OF; GESTODENE--ADMINISTRACTION AND DOSAGE; HEMIC SYSTEM; INCIDENCE; LEVONORGESTREL--ADMINISTRACTION AND DOSAGE; LEVONORGESTREL--SIDE EFFECTS; LIPID METABOLIC EFFECTS; LIPIDS; LONGITUDINAL STUDIES; MEASUREMENT; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDERS; METABOLIC EFFECTS; METRORRHAGIA; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; ORAL CONTRACEPTIVES, LOW-DOSE; PHYSIOLOGY; REPRODUCTION; RESEARCH METHODOLOGY; SIGNS AND SYMPTOMS; STEROID METABOLIC EFFECTS--ANALYSIS; STUDIES; WESTERN EUROPE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CLINICAL TRIALS; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL; FEMALE; HUMANS; LEVONORGESTREL; LIPIDS; LONGITUDINAL STUDIES; MENSTRUAL CYCLE; NORGESTREL; NORPREGNENES; PROGESTERONE CONGENERS; RANDOM ALLOCATION; STEREOISOMERISM;

EID: 0023529028     PISSN: 0020725X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)